Targeted In Vivo Imaging of Angiogenesis: Present Status and Perspectives

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|1|17-31

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.1, 2007-01, pp. : 17-31

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endothelial Cell Targeted Molecular Imaging in Tumor Angiogenesis: Strategies and Current Status

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 7, 2013-10 ,pp. : 644-657

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Imaging of σ1 Receptors In Vivo: Current Status and Perspectives

By  

Current Medicinal Chemistry, Vol. 21, Iss. 1, 2014-01 ,pp. : 35-69

Bentham Science Publishers

Access to resources Recommend Favorite

Contrast Agents and Applications to Assess Tumor Angiogenesis In Vivo by Magnetic Resonance Imaging

By  

Current Medicinal Chemistry, Vol. 14, Iss. 1, 2007-01 ,pp. : 77-91

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Receptor-Targeted Fluorescent Probes for In Vivo Cancer Imaging

By  

Current Medicinal Chemistry, Vol. 19, Iss. 28, 2012-10 ,pp. : 4742-4758

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-cytokine Ab immune therapy: present status and perspectives

By Zagury D.   Gallo R.C.  

Drug Discovery Today, Vol. 9, Iss. 2, 2004-01 ,pp. : 72-81

Elsevier

Access to resources Recommend Favorite